Cancer Council SA - Giving Day 2024

Thank you so much South Australia for your support of Cancer Council SA's very first Cancer Research Giving Day. Your donations will go towards world-class cancer research right here in South Australia.

Alongside with our matched-donors SCS Group, Sarah Construction and the Sue Chase Foundation, you raised:

$ 111,360

If you missed out on Giving Day, you can still donate today and help double-down on cancer.

It’s an incredible day when our generous matching donors double the impact of your kindness!

Our generous matched-donors

SCS Group Logo

SCS Group is a professional commercial cleaning company that offers a wide range of services to businesses within multiple industries. With national coverage across Australia, they are committed to delivering exceptional cleaning solutions tailored to the specific needs of valued customers. 

SCS Group are extremely proud of their transparent and inclusive culture prioritising diversity and equity to ensure everyone feels welcomed and empowered to thrive. As a family-owned business, they are deeply committed to creating a positive impact in their communities, building a better future for future generations.

A construction company based in South Australia, Sarah Constructions provide excellence in delivery, innovation and problem solving.
Starting in 1961, the Sarah family became a trusted name in the building industry by providing quality design and outstanding customer service. More than 60 years later Sarah has cemented itself as a leader in the industry and these values still remain at the forefront of every project they undertake—including the construction of Cancer Council SA’s new facility on Greenhill Road providing supportive accommodation for regional South Australians travelling to Adelaide for cancer treatments. 

Sarah Constructions Logo

The Sue Chase Foundation

Sue Chase was honoured as a Member of the Order of Australia for her charity work and giving back to the community through involvement ranging from chairing the Scotch College Foundation board to sitting on the Economic Development Board of South Australia.

Sue supports organisations including the Royal Flying Doctor Service, Cancer Council and Eyre Peninsula Community Foundation through the Sue Chase Foundation. We are thrilled Sue has chosen to support Cancer Council SA's inaugural Cancer Research Giving Day. 

Researcher Spotlights

Cancer Council SA is committed to funding world-class South Australian cancer research that is working to reduce the rate and impact of cancer. Thanks to the contribution of groundbreaking cancer research, more people are surviving cancer than ever before with cancer survival rates increasing by as much as 20 per cent since the 1980s.

Researcher - Kevin Fenix

Dr Kevin Fenix

University of Adelaide

Around 5,000 Australians die each year from bowel cancer, making it the second deadliest cancer in this country. While highly treatable when caught early, bowel cancer is deadly once it spreads throughout the body (a process known as metastasis).

Dr Fenix and his team are working with a new type of immunotherapy called cytokine-induced killer (CIK) cell therapy to develop a better, more effective version of this therapy as a treatment option for metastatic bowel cancer.

Dr Kerry Ettridge


Overweight and obesity, and poor diet, are leading risk factors for cancer, second only to tobacco. Australians over-consume foods and drinks high in saturated fat, salt and sugar, with consumption particularly high among young people. 

Dr Ettridge’s research aims to provide insight into the factors that influence parents’ purchase of foods and design and test an intervention designed to help parents identify unhealthy foods and drinks when shopping. 

Researcher - Kerry Ettridge
Researcher - Elyse Page

Dr Elyse Page


Children with Down Syndrome have an increased risk of developing acute lymphoblastic leukaemia. A critical issue for these patients is the spread of leukaemia from the blood to the brain, which is a common cause of relapse and requires toxic treatments to be injected directly into the spinal fluid to reach the brain.

Dr Page’s research hopes to identify an indicator in the blood, called a biomarker, to detect and treat leukaemia metastasis to the brain early to prevent relapse and reduce the need for chemotherapy in the spinal fluid for patients where it is not necessary.